While the multinational conglomerate Siemens AG announced plans today to remove its industrial businesses from Russia due to the ongoing invasion of Ukraine, the separately managed medtech division—Siemens Healthineers—will remain in the country and continue to provide its healthcare products and services.
The mainstay CT machine is about to see a major upgrade, with the FDA pitching its clearance of Siemens Healthineers’ new photon-counting scanner as the first major technological advance in the field in nearly a decade.
Varian, a Siemens Healthineers company, has announced that China Medical University Hospital in Central Taiwan treated its first patient with Ethos™ therapy, making it the first hospital in Taiwan and within the Greater China region to use Ethos therapy for advanced cancer treatment.
With the $300 million investment and expansion of the 500,000 square-foot facility, Siemens Healthineers, formerly Siemens Healthcare, will allow the company to hire up between 400 and 700 additional employees—which will double the number of people employed at the facility. The total hiring boom is expected to be completed by 2026, the company said. The $300 million investment is expected to be implemented over a four-year period, the company said.
Siemens AG announced plans to spin off its $15 billion health-care division in one of the German engineering giant’s biggest portfolio revamps as it narrows focus on energy, transport and factory gear.
Michael Popp’s faith in Russia is unshakable. nRuble trading near record lows? “Manageable.” Millions of Russians sinking into poverty? “Just remember the 1998 crisis.” The country facing the longest recession in two decades? “Now is the time to invest,” the Chief Executive Officer of German herbal-drug maker Bionorica SE said at a Russian business forum in Hamburg this week.